chalcone has been researched along with Diabetes Mellitus, Type 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, C; Gao, JQ; Gao, SQ; Li, LJ; Niu, XQ; Zhang, Y | 1 |
| Chen, R; Fang, Q; Jin, Y; Khan, Z; Li, W; Liang, G; Liu, Z; Shan, X; Wang, Y; Yu, W; Zou, C | 1 |
2 other study(ies) available for chalcone and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Topical application of Hydroxysafflor Yellow A accelerates the wound healing in streptozotocin induced T1DM rats.
Topics: Administration, Topical; Animals; Chalcone; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Human Umbilical Vein Endothelial Cells; Humans; Kinetics; Male; Nitric Oxide; Quinones; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A; Wound Healing | 2018 |
Blockade of myeloid differentiation 2 attenuates diabetic nephropathy by reducing activation of the renin-angiotensin system in mouse kidneys.
Topics: Animals; Cells, Cultured; Chalcone; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Kidney; Lymphocyte Antigen 96; Mice; Mice, Inbred C57BL; Mice, Knockout; Renin-Angiotensin System; RNA, Small Interfering; Streptozocin | 2019 |